A

ANNX

Annexon, Inc.

2.45

0.05+2.08%
After Hours: 2.460  +0.010  +0.41%16:31 08/01 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE2.350/2.400
TODAY RANGE2.290-2.470
VOL872.04K
MARKET CAP268.80M
52 WEEK RANGE1.285-7.85
AVG VOL (3M)1.52M
% TURNOVER0.79%
TURNOVER--
P/E (TTM)-2.1243
% RANGE7.49%
EPS(TTM)-1.1533
P/E(FORWARD)-1.6724
P/B1.103
BVPS2.222
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP249.13M
SHARES OUTSTANDING109.71M
NEXT EARNINGS08/11-08/15
FREE FLOAT101.69M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

R

Regeneron Pharmaceuticals

REGN

+2.46%
558.87

E

Entero Therapeutics

ENTO

-4.45%
0.4204

B

BIONTECH

BNTX

-0.15%
107.34

U

United Therapeutics Corp.

UTHR

+7.13%
294.28

V

Vertex Pharmaceuticals Inc

VRTX

+1.15%
462.13

S

Siga Technologie

SIGA

-2.27%
6.46

M

Moderna

MRNA

-6.61%
27.61

C

Charles Riv Labs Intl Inc

CRL

-1.61%
166.91

M

Medpace Holdings

MEDP

-0.96%
423.09

T

Talphera Inc

TLPH

-3.73%
0.4024

I

ICON PLC

ICLR

-1.63%
166.44

C

China Biologic

CBPO

--
119.99

I

Iqvia Hldgs Inc

IQV

-1.83%
182.45

M

MOLECULAR PARTNERS AG

MOLN

-4.59%
3.53

A

Arcturus Therape

ARCT

+0.74%
12.30

G

Gilead Sciences Inc

GILD

+0.79%
113.18

P

PRA Health

PRAH

--
165.21

I

Incyte Corp

INCY

+0.93%
75.59

A

Aptevo Therapeutics Inc

APVO

-3.94%
2.68

B

Biospecifics

BSTC

+0.15%
88.53
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.